Medical Care Facilities · Healthcare
CFO
2026-05-01–2023-07-10
Equibles does not estimate personal net worth.
Earlier roles on record: CFO at Acadia Healthcare Company, Inc. (ACHC) until July 10, 2023. Acadia Healthcare Company, Inc. reported in an 8-K filed April 23, 2026 that David Duckworth was appointed Interim Chief Financial Officer, effective May 1, 2026. Acadia Healthcare Company, Inc. reported in an 8-K filed July 5, 2023 that David Duckworth resigned as Chief Financial Officer, effective July 9, 2023. Acadia Healthcare Company, Inc. reported in an 8-K filed July 5, 2023 that David Duckworth resigned as Chief Financial Officer, effective July 10, 2023. Equibles holds 4 filed executive changes naming David Duckworth; each is listed under recent activity with its source filing. The proxy statement of Acadia Healthcare Company, Inc. reports total compensation of $3,659,902 for David Duckworth in fiscal 2021, including a base salary of $654,625. Disclosed compensation is on record for 5 fiscal years. David Duckworth has spoken on 13 earnings calls across 1 company, most recently for Acadia Healthcare Company, Inc. on April 26, 2023. The companies whose calls David Duckworth spoke on are classified in the Healthcare sector.
“Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ: ACHC) today announced the appointment of David Duckworth, former Chief Financial Officer of Acadia, as Interim Chief Financial Officer, effective May 1, 2026.”
“Executive shall continue to serve as CFO of the Company until July 9, 2023 (the "CFO Resignation Date"), upon which date Executive shall resign, and shall be automatically deemed to have resigned without the requirement of any further action, from his position as CFO of the Company.”
“Our first quarter financial performance marked a great start to 2023 with 14.2% year-over-year revenue growth. Revenue for the first quarter of 2023 was $704.3 million compared with $616.7 million for the first quarter of 2022, reflecting the robust demand for our services with favorable volume trends.”
“In the fourth quarter, we achieved strong financial and operational results, successfully meeting our key performance metrics and demonstrating consistent execution of our strategy.”
“Looking at the third quarter, we delivered strong financial and operating results as we successfully delivered on our key performance metrics through consistent execution of our strategy.”
“Looking at the second quarter, we delivered strong financial and operating results as we successfully delivered on our key performance metrics, demonstrating consistent execution of our strategy.”
“Looking at the first quarter, we delivered a solid financial and operating performance marking a strong start to 2022. While we faced some early challenges in January related to the surge of the Omicron variant of COVID-19, our operating trends recovered quickly with meaningful improvement in February and March.”
2026-05-01–2023-07-10
Start not stated–2023-07-10
Medical Care Facilities · Healthcare
CFO
2026-05-01–2023-07-10
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Acadia Healthcare Company, Inc. (ACHC) | CFO | $654,625 | $3,659,902 |
| 2020 | Acadia Healthcare Company, Inc. (ACHC) | CFO | $635,558 | $2,739,716 |
| 2019 | Acadia Healthcare Company, Inc. (ACHC) | CFO | $623,096 | $2,153,884 |
| 2018 | Acadia Healthcare Company, Inc. (ACHC) | CFO | $610,878 | $1,739,062 |
| 2017 | Acadia Healthcare Company, Inc. (ACHC) | CFO | $598,900 | $1,824,135 |